This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Invitrogen announced this week that it had reached an agreement to sell its long-struggling BioReliance unit to private equity firm Avista Capital Partners for approximately $210 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.